Table 5 Logistic Regression Model: Medical treatment in participants with hypertension (including unknown hypertension) or dyslipidemia (including unknown dyslipidemia), respectively

Effect

OR

95% CI

p-value

OR

95% CI

p-value

Diabetes

yes

2.86

2.44-3.35

<0.0001

1.38

1.15-1.65

0.0006

Age

year

1.07

1.06-1.07

<0.0001

1.06

1.05-1.07

<0.0001

Sex

male

0.64

0.58-0.70

<0.0001

0.59

0.52-0.67

<0.0001

Study

KORA

1.33

1.15-1.54

<0.0001

1.25

1.01-1.53

0.0383

CARLA

1.95

1.66-2.30

<0.0001

1.94

1.53-2.50

<0.0001

DHS

0.93

0.77-1.12

0.4219

*-

-

-

HNR

1.96

1.73-2.22

<0.0001

1.96

1.64-2.33

<0.0001

SHIP

1.68

1.47-1.93

<0.0001

1.27

1.03-1.56

0.0232

GNHIES98

Ref.

Ref.

Interactions

Effect

OR

95% CI

p-value

OR

95% CI

p-value

Age*Diabetes

0.0581

0.0037

Age*Sex

0.0001

0.6613

Age*Study

0.0006

0.0295

Stratification

Age (year)

T2D

1.02

1.00-1.05

0.0593

Non-T2D

1.06

1.05-1.07

<.0001

Age (year)

Men

1.08

1.07-1.09

<.0001

Women

1.05

1.04-1.06

<.0001